Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...

The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 ...

The approval comes amid regulatory upheaval under HHS head Robert F. Kennedy Jr., who has pushed for changes around mRNA ...

Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19 disease CAMBRIDGE, MA / ACCESS Newswire / July 10, 2025 / ...

The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 ...

The Stratus COVID-19 variant, which includes the XFG and XFG.3 strains, currently accounts for around 30 per cent of COVID-19 ...

The US FDA has granted full approval to Moderna’s COVID-19 vaccine Spikevax for use in children aged six months to 11 years ...

Moore also faces a charge of destruction of evidence for allegedly ordering his former office manager, Kari Dee Burgoyne, to ...

In a significant legal challenge that could reshape the future of public health policy in the United States, a powerful ...

The percentage of parents seeking waivers for vaccinations for religious or other reasons has nearly doubled from 2020 to 2024, an analysis found.

House Democrats on the Oversight Committee are calling for an urgent briefing with staff from the Centers for Disease Control ...

Moderna's Spikevax was previously available for paediatric populations under emergency use authorisation. Moderna expects to make its updated vaccine available for eligible  US population for the 2025 ...